#TheLancet

Eric Feigl-Ding

DrEricDing

BREAKING—analysis of Russian #SARSCoV2 vaccine’s phase 3 trial with ~ 20,000 participants finds that a 2-dose regimen has an efficacy of 91.6% against symptomatic #COVID19. No serious adverse events were

Dr Michelle Kelly-Irving

shell_ki

The difficult choice of keeping schools open or not during lockdown is a social inequality & child welfare issue affecting life course trajectories in wellbeingA lot is at stake, so

Mac n’ Chise 🧬🧫🦠

sailorrooscout

Let’s discuss SARS-CoV-2 variants, selective pressure, and mutations. In the face of variants, our best protection is to get more people vaccinated. Vaccination will not automatically select for vaccine-resistant variants,

Allen Cheng

peripatetical

Why would we use a vaccine that mightn't prevent transmission? Should we use one particular vaccine, or roll out the vaccines we have as broadly and quickly as possible? I'd

Infectious Disease Ethics

ID_ethics

Terminology thread:rate ≠ riskinfection ≠ diseasequarantine ≠ isolationsocial distancing ≠ physical distancingprolonged PCR positivity ≠ sheddingvirulence ≠ transmissibility References to follow 1/ rate ≠ riskA risk is a proba

🏳️‍🌈Rosie Weatherley🏳️‍🌈

tweetyposie

I’ve been contacted by a few friends and family members recently, asking for some tips on how to support the mental health of teams of healthcare staff (my family’s full

Adam Townsend

adamscrabble

Are we obligated to suspend disbelief that Tom Hanks and assorted A and B list Hollywood buskers are testing positive for coronavirus at a statistically almost impossible rate? It seems

David Fisman

DFisman

Vaccine prioritization in phase II in Ontario: the province has put out a framework, which seems not unreasonable (https://toronto.ctvnews.ca/ontario-releases-list-of-those-eligible-for-covid-19-vaccine-under-phase-2-1.5264702?cache=ngyhfzx

Katerini T. Storeng

KStoreng

Highly recommend ⁦@TimothyWSchwab⁩ piece in @thenation unpacking how the links between ⁦@gatesfoundation⁩ ⁦@IHME_UW⁩ and ⁦@TheLancet⁩ shape global health data. Luckily, not all scholars have succumbed to the “Bill Chill”

Deepta Bhattacharya

deeptabhattacha

I received this email from someone last week that I can't stop thinking about. I probably received this since I have been openly optimistic about vaccine efforts. So I wanted

Prof. Akiko Iwasaki

VirusesImmunity

How well do various vaccines reduce severe COVID disease & death? Awesome @YaleMed students, @dariusdariusdar, @ChaneyKalinich, @Larson_HaleighT & Caroline Valdez put together summary tables from vaccine trials. Remarkable ability o

Naomi O'Leary

NaomiOhReally

My understanding of AstraZeneca's EU doses:- contract signed in August- EU expected over 100 mln doses delivered by end-March, possibly 120 mln- in early Dec, AZ revised down to 80

Edward Nirenberg

ENirenberg

So, every so often I get people who come to my twitter after I debunked something and tell me all about how the effort was noble but the denialists won't

Tom Wenseleers

TWenseleers

(1/10) What genomic features make SARS-CoV2 more pathogenic? A study in PNAS looked into this: https://www.pnas.org/content/117/26/15193. "Distinct inserts in the spike glycoprotein are associated with high case fatality rate of

Federico Andrade Rivas

andradefederico

Planetary health (“health of human civilization and the state of the natural systems”) is an emerging holistic health field that is gaining momentum. Excited about it, we decided to review

Dr Simon Mair

simon_mair

I have new open access paper in @TheLancetPlanet. It's a theoretical framework that aims to shed light on some reasons that neoliberal capitalism is struggling with COVID, despite having such

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.